News

Testing drug sensitivity on tumor tissue at physiological oxygen levels could act as a new screening method for drug efficacy.

A computational biology researcher has reported a cross-reaction between Bacillus Calmette-Guérin and SARS-CoV-2 that might help explain what could be driving immunity brought on by the BCG vaccination.

The World Health Organization (WHO) has strongly recommended the drug baricitinib for patients with severe or critical COVID-19 in combination with corticosteroids. In the same guideline update, it also makes a conditional recommendation for the use of the monoclonal antibody sotrovimab in patients with non-severe disease, but only in those at the highest risk of hospitalization.

An international metastudy led by researchers at Karolinska Institutet in Sweden has identified a specific gene variant that protects against severe COVID-19 infection.

Significant metabolic differences have been identified in malignant cells, offering a new avenue for cancer therapies.

By studying the plant Arabidopsis thaliana, researchers have found that RNA messages need a special protein to escort them where they need to go and without this escort, the plant fails to develop properly.

Software-analyzed high-resolution videos have revealed that dengue-infected mosquitos are more attracted to mammals and bite more often, tripling disease transmission opportunities.

By combining epidemiological mapping and community outreach, researchers are targeting educational interventions to populations in Philadelphia at the highest risk for prostate cancer.

The demyelinating neurodegenerative disease multiple sclerosis (MS) is a complication of infection by the Epstein-Barr virus (EBV), suggests a new study published in Science by researchers at Harvard Medical School.

Scientists from Yale University have developed a wearable air sampler that has been tested for its ability to detect airborne SARS-CoV-2. The study results are published in Environmental Science and Technology Letters.